<DOC>
	<DOCNO>NCT02968966</DOCNO>
	<brief_summary>Genetic epileptic encephalopathy ( EEs ) group rare severe , pharmaco-resistant epilepsy form characterize early onset , e.g . first year life , often severe developmental delay . Genetic defect find different ion channel potassium sodium channel explain well pathological neuronal hyperexcitability lead seizure . Further mutation also find protein relevant cell structure , DNA/RNA process synaptic vesicular metabolism . Specific individualized therapy establish neither clinical routine control study . The goal monocentric non-blinded non-placebo control phase IIb study evaluation effectivity anticonvulsive drug specifically work ion channel defective subtypes EEs order establish standard individualized therapy rare disease base specific genetic defect .</brief_summary>
	<brief_title>Pathophysiology Based Therapy Early Onset Epileptic Encephalopathies</brief_title>
	<detailed_description>During study , sodium channel blocker phenytoin lacosamide potassium channel blocker kinidinsulfate give standardized condition patient early onset pharmaco-resistant genetic epilepsy without mutation potassium channel KCNT1 KCNQ2 sodium channel gene SCN2A . The primary endpoint significant seizure reduction trial medication compare baseline . Secondary endpoint improvement electroencephalographic characteristic respective EEs .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>highly active epilepsy ( â‰¥ 1 seizure per day ) epilepsy onset 03 month age pharmacoresistant epilepsy ( 2 standard anticonvulsive medication try ) recently max . two stable anticonvulsive drug minimum 4 day study start patient continuous monitor control patient young 1 year age high grade cardial rhythm disorder severe liver , renal electrolyte blood parameter change metabolic lesional origin epilepsy ( metabolic screening result cranial MRI available ) parallel participation study ( must finish two month study start ) miss inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>